Baranova
Ancha Baranova, Annandale, VA US
Patent application number | Description | Published |
---|---|---|
20090004735 | Promoter and its use - A promoter comprising nucleotides from positions 2489-3038 of FIG. | 01-01-2009 |
20110206642 | Preventing obesity-related metabolic syndrome with melagonesis - Anti-inflammatory effect of α-MSH-like compounds can be employed for curtailing sequelae of obesity and overweight. Importantly, molecular compounds that stimulate melanin biosynthesis by mimicking the effects of α-MSH are readily available for trials aimed at control of metabolic syndrome components. Synthetic agonists of α-MSH receptors, melanotan II and bremelanotide, have already been proven safe in human trials for therapeutic tanning and some non-obesity-related diseases. | 08-25-2011 |
20110301853 | Tumor Discriminator - A tumor discriminator determines if a biological sample is diseaseous. Summarized expression value samples in a reference dataset are determined. The summarized expression value being a summation of gene expression levels for disease and normal samples. A biological sample summarized expression value is determined using a gene expression profile for a biological sample. A disease sample distance is estimated from the biological sample summarized expression value to a location in the disease sample space. The disease sample space defined by a statistical analysis of the disease samples. A normal sample distance is estimate from the biological sample summarized expression value to a location in the normal sample space The normal sample space defined by a statistical analysis of the normal samples. The disease sample distance is compared with the normal sample distance to determine if the biological sample is diseaseous. | 12-08-2011 |
20130183687 | METHODS OF DIAGNOSING NON-ALCOHOLIC STEATOHEPATITIS (NASH) - Non-invasive methods for detecting non-alcoholic fatty liver disease (NAFLD) and identifying the presence or absence of non-alcoholic steatohepatitis (NASH) in a subject utilize one or more biomarkers. The methods can differentiate between subjects with NASH and those with simple steatosis. Kits containing one or more agents for measuring the level of the biomarkers can be utilized to perform the described methods. | 07-18-2013 |
Ancha V. Baranova, Annandale, VA US
Patent application number | Description | Published |
---|---|---|
20080311593 | METHODS OF DIAGNOSING NON-ALCOHOLIC STEATOHEPATITIS (NASH) - Non-invasive methods for detecting non-alcoholic fatty liver disease (NAFLD) and identifying the presence or absence of non-alcoholic steatohepatitis (NASH) in a subject utilize one or more biomarkers. The methods can differentiate between subjects with NASH and those with simple steatosis. Kits containing one or more agents for measuring the level of the biomarkers can be utilized to perform the described methods. | 12-18-2008 |
20090306185 | Nanogenomics for medicine: siRNA engineering - Described herein are materials and methods for the delivery of siRNA and the production of nanoparticles useful for the delivery of siRNA. Methods of treating a disease or disorder using the nanoparticles described herein also are disclosed. | 12-10-2009 |
20110009279 | Methods of Diagnosing Non-Alcoholic Steatohepatitis (NASH) - Non-invasive methods for detecting non-alcoholic fatty liver disease (NAFLD) and identifying the presence or absence of non-alcoholic steatohepatitis (NASH) in a subject utilize one or more biomarkers. The methods can differentiate between subjects with NASH and those with simple steatosis. Kits containing one or more agents for measuring the level of the biomarkers can be utilized to perform the described methods. | 01-13-2011 |
20130045243 | NANOGENOMICS FOR MEDICINE: siRNA ENGINEERING - Described herein are materials and methods for the delivery of siRNA and the production of nanoparticles useful for the delivery of siRNA. Methods of treating a disease or disorder using the nanoparticles described herein also are disclosed. | 02-21-2013 |
Ganna Ivanivna Baranova, Kiev UA
Patent application number | Description | Published |
---|---|---|
20090182118 | METHOD FOR PRODUCING POLYGUANIDINES - The invention relates to polyguanidine synthesis. The inventive method for producing polyguanidines consists in polycondensing a guanidine salt with diamine during heating in the presence of an organic acid or a mixture of organic acids. A heating process is carried out stepped process and consists in gradually increasing a temperature up to 120-130° C. and in holding at said temperature for 0.5-1.0 hour, in increasing a temperature up to 150-160° C. and in holding at said temperature for 3.5-4.0 hours and in increasing a temperature up to 170-180° C. and in holding at said temperature for 1.0-1.5 hours. Said method makes it possible obtain, in a more full manner and in shorter time, a polyguanidine, which exhibits a high biological activity. The thus obtained polyguanidines are not toxic and can be efficiently used for treating drinking and sewage waters and for producing antiseptic, cosmetic and disinfecting agents. | 07-16-2009 |
Irina N. Baranova, Bethesda, MD US
Patent application number | Description | Published |
---|---|---|
20090011974 | Scavenger Receptor B1 (Cla-1) Targeting for the Treatment of Infection, Sepsis and Inflammation - This invention relates to methods and compositions for the treatment of sepsis, inflammation or infection. In particular, the invention concerns the use of molecule(s) that target SR-BI, which is also referred to as CLA-1 (SR-BI/CLA-1), to treat sepsis, bacterial and viral infections, and inflammatory diseases. SRB I/CLA- | 01-08-2009 |